AAV1.NT-3 gene therapy in the SOD1KO mouse model of accelerated sarcopenia.

J Cachexia Sarcopenia Muscle · 2023 · PMC10570084 · PMID 37553101

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In addition, the phosphorylation of 4EBP1 also showed a trend of increase after NT‐3 treatment.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.